KVUE Kenvue Inc.

$16.66

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Kenvue, Inc. (KVUE) is poised for its upcoming earnings announcement on October 23, 2025, with market watchers keenly observing whether the company can surpass the whisper number of $0.27 EPS, slightly above the consensus estimate of $0.26. This subtle yet significant difference underscores the market's cautious optimism about Kenvue's ability to leverage its strategic initiatives effectively. With a robust market cap of approximately $31.95 billion, Kenvue's anticipated revenue of $3.82 billion will be a critical indicator of its operational strength and market positioning. The absence of recent news leaves investors focusing on Kenvue's historical performance and strategic execution as they assess its potential to meet or exceed expectations. As the earnings date approaches, the key question remains whether Kenvue can deliver results that align with the market's quiet confidence, as reflected in the whisper number, and continue to build on its financial foundation.

Updated On 11/16/2025

About Kenvue Inc.

Kenvue Inc. is a consumer health company globally.

Website: https://www.kenvue.com

Sector
LIFE SCIENCES
Industry
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1944048
Address
199 GRANDVIEW ROAD, SKILLMAN, NJ, UNITED STATES
Valuation
Market Cap
$44.88B
P/E Ratio
43.31
PEG Ratio
2.39
Price to Book
4.64
Performance
EPS
$0.54
Dividend Yield
3.51%
Profit Margin
6.67%
ROE
9.87%
Technicals
50D MA
$22.76
200D MA
$21.91
52W High
$24.36
52W Low
$17.18
Fundamentals
Shares Outstanding
2B
Target Price
$24.21
Beta
nan

KVUE EPS Estimates vs Actual

Estimated
Actual

KVUE News & Sentiment

Nov 14, 2025 • Benzinga NEUTRAL
Kimberly-Clark, Thermo Fisher Scientific On CNBC's 'Final Trades' - Kimberly-Clark ( NASDAQ:KMB ) , Thermo Fisher Scientific ( NYSE:TMO )
On CNBC's "Halftime Report Final Trades," Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, LLC, picked Kimberly-Clark Corporation ( NYSE:KMB ) . "[Kimberly-Clark] is still oversold after the Kenvue announcement," Harrington says, citing its 5% dividend yield.
Nov 13, 2025 • Benzinga SOMEWHAT-BULLISH
Decoding Johnson & Johnson's Options Activity: What's the Big Picture? - Johnson & Johnson ( NYSE:JNJ )
Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson ( NYSE:JNJ ) we detected 8 trades.
Nov 13, 2025 • Motley Fool SOMEWHAT-BULLISH
2 Strong Healthcare Stock Picks for Dividend Investors
These top dividend payers could enrich a long-term investor's portfolio.
Nov 11, 2025 • Motley Fool NEUTRAL
3 Beaten-Down Stocks That Haven't Been This Cheap in Over 5 Years
These stocks are down between 20% and 57% this year.
Nov 06, 2025 • Motley Fool SOMEWHAT-BULLISH
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.
Ultra-high yields don't have to translate to ultra-high risk.
Nov 05, 2025 • Benzinga SOMEWHAT-BULLISH
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. ( NYSE - KVUE ) , Sonida Senior Living, Inc. ( NYSE - SNDA ) , Evoke Pharma Inc. ( Nasdaq - EVOK ) , SM Energy Company ( NYSE - SM )
BALA CYNWYD, Pa., Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
Sentiment Snapshot

Average Sentiment Score:

0.197
50 articles with scored sentiment

Overall Sentiment:

Bullish

KVUE Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $0.29
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 3.6%
May 08, 2025
Mar 31, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $0.24
  • Estimate: $0.23
  • Whisper:
  • Surprise %: 4.3%
Feb 06, 2025
Dec 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.26
  • Whisper:
  • Surprise %: 0.0%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.27
  • Whisper:
  • Surprise %: 3.7%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 14.3%
May 07, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.25
  • Whisper:
  • Surprise %: 12.0%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 10.7%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.31
  • Estimate: $0.31
  • Whisper:
  • Surprise %: 0.0%
Jul 20, 2023
Jun 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.30
  • Whisper:
  • Surprise %: 6.7%

Financials